In 1747, Scottish naval surgeon James Lind conducted what is now considered the world’s first controlled clinical trial aboard HMS Salisbury. Scurvy, a deadly disease causing bleeding gums and ...

Here are some common barriers to clinical trial participation — and potential work-arounds you may be able to implement with the help of your care team. Challenge 1: Strict Eligibility Criteria ...

Clinical trial finds diabetes pill reduces liver scarring. ScienceDaily. Retrieved June 11, 2025 from www.sciencedaily.com / releases / 2025 / 06 / 250606231301.htm. BMJ Group.

Clinical trial participation often requires a larger time commitment than standard care. But some people find this worthwhile, because the cancer’s progression is monitored more closely ...

Please use one of the following formats to cite this article in your essay, paper or report: APA. Francisco de Souza, Hugo. (2025, June 04). AI-designed drug shows early promise for lung fibrosis ...

Trial design This trial was for people with pancreatic cancer or bowel (colorectal) cancer that had spread. The trial was in 2 parts. In part 1, people had different doses of plerixafor. The first few ...

Exercise is generally good for you, but a new high-quality clinical trial finds that it's so good, it can even knock back colon cancer—and, in fact, rival some chemotherapy treatments.

R-ALPS: A randomized, double-blind, placebo-controlled, multicenter phase III clinical trial of TQB2450 with or without anlotinib as maintenance treatment in patients with locally advanced and ...

China’s first clinical trial of a technology that allows signals from the brain to control an external device has shown early signs of success, making it only the second country after the US to ...

The trial was sponsored by Sheffield Teaching Hospitals NHS Foundation Trust and conducted by the Leeds Cancer Research UK Clinical Trials Unit at the University of Leeds.

Thinking about taking Ozempic but worried about losing too much muscle? New clinical trial data might point to a future where that’s no longer a concern. Regeneron Pharmaceuticals announced the ...

FIRST/ENGOT-OV44: A phase 3 clinical trial of dostarlimab (dost) and niraparib (nira) in first-line (1L) advanced ovarian cancer (aOC). This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...